Timothy Miller

Timothy Miller, MD, PhD

Specializes In
  • Neurology
  • Adult Neurology
Languages Spoken
  • English
  • French

Appointments

Sees Patients For

ALS, motor neuron disease, neurological disorders

Hospital Affiliations

  • Barnes-Jewish Hospital

Locations

Experience

Board Certifications

  • Neurology
  • Psychiatry

Academic Title(s)

David Clayson Professor of NeurologyNeuromuscular Division

Research Interests

Dr. Miller's research includes innovative treatments, with a focus on therapeutic strategies that turn off harmful genes in the brain and spinal cord in patients with neurodegenerative diseases. millerlab.wustl.edu | alscenter.wustl.edu

Publications & Research

View research profile »

Education

Medical Degree

1998 Washington University School of Medicine, St. Louis, MO

PhD

1998 Washington University School of Medicine, St. Louis, MO

Residency

2003 Neurology, University of California, San Francisco

Fellowship

2003 Neuromuscular, University of California, San Francisco

BS, BA

1991 University of Virginia, Charlottesville, VA

Financial Disclosures
  • Biogen
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2024
  • Ionis Pharma
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2024

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.